KULICKE & SOFFA INDUSTRIES INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data KULICKE & SOFFA INDUSTRIES INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	627	809	889	540	623	1,518	1,504	742	706	654
Cost of revenue	346	427	480	285	325	821	755	384	437	376
Gross profit	281	382	409	255	298	697	748	359	269	278
Research and development	92.4	100	120	116	123	137	137	145	151	150
Selling, general and administrative	135	134	123	117	116	147	140	153	166	168
Operating expenses	227	269	243	233	239	285	278	319	361	281
Operating income	54	113	167	21.6	58.5	412	470	39.4	-92.5	-3.22
Interest expense	1.11	1.06	1.05	2.06	1.72	0.22	0.21	0.14	0.09	0.13
Interest income	3.32	6.49	12	15.1	7.54	2.32	7.12	32.9	34.2	23.8
Pre-tax income	56.2	119	178	34.7	64.3	415	477	72.2	-58.4	20.5
Income tax	7.71	-7.39	121	22.9	12	47.3	43.4	15.1	10.7	20.3
Net income	48.5	126	56.7	11.7	52.3	367	434	57.1	-69	0.21
EBITDA	70.2	129	186	41.9	78.2	432	491	68.3	-67.8	14.8
EPS, basic	0.69	1.78	0.82	0.18	0.83	5.92	7.21	1.01	-1.24	0.00
EPS, diluted	0.68	1.75	0.80	0.18	0.83	5.78	7.09	0.99	-1.24	0.00
Shares, basic (weighted)	70.5	70.9	69.4	65.3	62.8	62	60.2	56.7	55.6	53
Shares, diluted (weighted)	70.8	72.1	70.4	65.9	63.4	63.5	61.2	57.5	55.6	53.2
Dividend per share	0.00	0.00	0.24	0.48	0.48	0.56	0.17	0.19	0.80	0.82

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	424	392	321	364	188	363	556	529	227	216
Short-term investments	124	216	293	229	342	377	220	230	350	295
Receivables	130	198	243	196	199	421	309	159	194	184
Inventory	87.3	122	115	89.3	112	167	185	217	178	160
Other current assets	15.3	23.9	14.6	15.4	19.6	23.6	62.2	53.8	46.2	47.1
Total current assets	781	953	987	894	860	1,352	1,332	1,189	995	902
Property, plant and equipment	50.3	67.8	76.1	72.4	59.1	68	80.9	110	64.8	59
Lease right-of-use assets				0	22.7	41.6	41.8	47.1	35.9	32.2
Goodwill	81.3	56.3	56.6	55.7	56.7	72.9	68.1	88.7	89.7	69.5
Intangible assets	50.8	62.3	52.9	42.7	38	42.8	31.9	29.4	25.2	5.6
Other non-current assets	2.26	2.06	2.59	2.49	2.19	2.36	2.87	3.22	8.43	3.41
Total assets	982	1,171	1,186	1,080	1,055	1,602	1,589	1,500	1,240	1,104
Accounts payable	41.8	51.4	48.5	36.7	57.7	155	67.3	49.3	58.8	57.2
Accrued liabilities	24.2	47.4	34.9	26.3	22.8	72.5	58.9	35.7	31	33.4
Total current liabilities	126	193	174	175	158	352	249	182	184	188
Lease liabilities				0	18.3	38.1	34.9	41.8	33.2	32.4
Other non-current liabilities	12.9	8.43	9.19	9.36	12.4	14.2	11.7	11.8	13.2	10.2
Total liabilities	183	251	306	311	297	506	394	325	296	283
Retained earnings	443	569	614	595	616	949	1,342	1,356	1,243	1,200
Treasury stock	-139	-158	-249	-349	-395	-400	-676	-737	-882	-974
Other comprehensive income	-2.73	2.04	-3.9	-9.94	-2.52	-3.02	-32.9	-21.8	-13.4	-23.9
Shareholders' equity	800	920	880	769	758	1,095	1,195	1,175	944	821
Total equity	800	920	880	769	758	1,095	1,195	-21.8	-13.4	821
Total liabilities and equity	982	1,171	1,186	1,080	1,055	1,602	1,589	1,500	1,240	1,104
Shares outstanding	70.4	70.2	67.1	63.2	61.6	61.9	57.1	56.3	53.9	51.9

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	48.5	126	56.7	11.7	52.3	367	434	57.1	-69	0.21
Depreciation and amortization	16.2	16.3	19	20.3	19.7	19.8	21.3	28.9	24.7	18
Stock-based compensation	5.73	11.7	11.7	14.3	15	15.5	19	22.7	26.9	28.5
Deferred income tax	-15.5	-16.8	22.5	8.83	-0.83	-9.82	-8.65	-4.48	11.4	2.75
Change in inventory	-16.3	-47.4	1.63	24.1	-26.2	-52.7	-14.9	-35.8	-31.5	-26.1
Change in payables	32.7	63.4	-30.9	-53.8	38.1	182	-129	-52.3	0.19
Cash from operations	68.4	136	123	66	94.4	300	390	173	31	114
Capital expenditures	-6.22	-25.6	-20.5	-11.7	-11.7	-22.8	-23	-44.4	-16.1	-17.2
Acquisitions	0	-27.1	0	0	0	-26.3	0	-36.9	0	0
Purchases of investments	-124	-305	-684	-619	-442	-507	-469	-595	-690	-585
Sales and maturities of investments								585	570	640
Cash from investing	-129	-145	-96.9	47.5	-126	-81.7	134	-91.3	-139	27.7
Stock issued	0.41	0.51	0.06	0.01	0	0
Share buybacks	-14.6	-18.2	-90.3	-99.9	-54.5	-10.4	-281	-69.2	-151	-97.1
Dividends paid	0	0	-8.18	-31.6	-30.2	-33.5	-39.4	-42	-44.2	-54.1
Cash from financing	-14.5	-22.7	-99.1	-71.3	-146	-44.3	-321	-112	-196	-153
Exchange rate effect	0.54	0.08	0.72	0.92	1.3	0.59	-10	3.68	1.31
Net change in cash	-74.7	-31	-71.8	43	-176	175	193	-26.1	-302	-11.4
Free cash flow	62.2	111	103	54.2	82.7	277	367	129	14.9	96.4
Interest paid	1.11	1.06	1.05	1.63	1.72	0.22	0.21	0.14	0.09	0.13
Income taxes paid	10	8.28	13.2	22.1	13.3	51.9	50.3	56.3	22.8	23.7

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 4, 2026; growth uses fiscal years. Valuation uses the share price of $91.18 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	48.2%	Gross profit / revenue.
Operating margin	13.2%	Operating income / revenue.
EBITDA margin	14.8%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	15.2%	Pre-tax income / revenue.
Net margin	12.2%	Net income / revenue.
FCF margin	4.3%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	5.8%	Cash from operations / revenue.
Effective tax rate	19.9%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	12.7%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	8.8%	Net income / average total assets.
Return on invested capital (ROIC)	18.5%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	17.0%	Research and development expense / revenue.
SG&A / revenue	18.0%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	2.9%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.5%	Capital expenditures / revenue.
D&A / revenue	1.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-7.4%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-24.2%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	1.0%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	3.4%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-28.1%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-1.4%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA CAGR, 3y	-68.9%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-28.4%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income CAGR, 3y	-92.1%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-66.7%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS CAGR, 3y	-91.7%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-65.6%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	265.9%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-33.7%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	3.8%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	547.2%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-36.0%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	3.1%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	2.5%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	69.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	11.3%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-13.0%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-11.7%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	1.6%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-11.0%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-11.4%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	0.9%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-4.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-4.6%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-3.4%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	3.44x	Current assets / current liabilities.
Quick ratio	2.64x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	1.61x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	30.9%	Total liabilities / total assets.
Interest coverage	837x	Operating income / interest expense.
Working capital	$784.2M	Current assets - current liabilities.
Goodwill and intangibles / assets	5.6%	(Goodwill + intangible assets) / total assets.
Tangible book value	$837.8M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.72x	Revenue / average total assets.
Fixed asset turnover	14.3x	Revenue / average property, plant and equipment.
Inventory turnover	2.17x	Cost of revenue / average inventory.
Days inventory	168 days	365 x average inventory / cost of revenue.
Receivables turnover	2.88x	Revenue / average receivables.
Days sales outstanding	127 days	365 x average receivables / revenue.
Days payables	87 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	208 days	Days inventory + days sales outstanding - days payables.
FCF conversion	35.5%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	25.4%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$2.17	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$17.78	Revenue / diluted weighted shares.
FCF per share	$0.77	Free cash flow / diluted weighted shares.
Operating cash flow per share	$1.03	Cash from operations / diluted weighted shares.
Book value per share	$17.43	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$16.01	Tangible book value / shares outstanding.
Cash per share	$9.87	(Cash + short-term investments) / shares outstanding.
Payout ratio	37.0%	Dividends paid / net income, when net income is positive.
Dividends / FCF	104.2%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	59.3%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$4.77B	Share price x shares outstanding.
Enterprise value	$4.25B	Market cap + total debt - cash - short-term investments.
P/E	41.2x	Market cap / net income. Only when net income is positive.
P/S	5.02x	Market cap / revenue.
P/B	5.23x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	5.70x	Market cap / tangible book value, when positive.
P/FCF	116x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	86.6x	Market cap / cash from operations, when positive.
EV/Sales	4.48x	Enterprise value / revenue.
EV/EBIT	33.9x	Enterprise value / operating income, when both are positive.
EV/EBITDA	30.2x	Enterprise value / EBITDA, when both are positive.
EV/FCF	103x	Enterprise value / free cash flow, when both are positive.
FCF yield	0.9%	Free cash flow / market cap.
Earnings yield	2.4%	Net income / market cap (the inverse of P/E).
Dividend yield	0.9%	Dividends paid over the period / market cap.
Shareholder yield	1.4%	(Dividends paid + share buybacks) / market cap.

What was KULICKE & SOFFA INDUSTRIES INC's revenue in fiscal 2025?

KULICKE & SOFFA INDUSTRIES INC reported revenue of $654.1M for fiscal 2025, 7.4% lower than the year before.

Was KULICKE & SOFFA INDUSTRIES INC profitable in fiscal 2025?

Yes. Net income was $213.0K, a net margin of 0%.

How much free cash flow did KULICKE & SOFFA INDUSTRIES INC generate in fiscal 2025?

Cash from operations of $113.6M minus capital expenditures of $17.2M left free cash flow of $96.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to KULICKE & SOFFA INDUSTRIES INC